Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Cancer|August 28, 2025
The legend of the response evaluation criteria in solid tumors: A historical overviewIllaa Smesseim, Kevin B W Groot Lipman, Ferry Lalezari, et al.Insights Into Imaging|July 1, 2026
Assessing the reliability of Response Evaluation Criteria In Solid Tumors (RECIST): a systematic review of the factors contributing to inter-observer variabilityIllaa Smesseim, Teresa T Bucho, Renaud Tissier, et al.Journal of Vascular and Interventional Radiology : JVIR|September 7, 2007
Angioplasty with or without stent placement in the brachiocephalic artery: feasible and durable? A retrospective cohort studyEline S van Hattum, Jean-Paul P M de Vries, Ferry Lalezari, et al.The Lancet. Respiratory Medicine|January 21, 2019
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trialMaria J Disselhorst, Josine Quispel-Janssen, Ferry Lalezari, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 21, 2017
Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature reviewFrancine E M Voncken, Berthe M P Aleman, Jolanda M van Dieren, et al.Plos One|December 21, 2017
Optimal endobronchial tool sizes for targeting lung lesions based on 3D modelingTorre M Bydlon, Gerrit C Langhout, Ferry Lalezari, et al.Practical Radiation Oncology|April 22, 2022
Bronchial Stenosis in Central Pulmonary Tumors Treated With Stereotactic Body Radiation TherapyBarbara L T Rijksen, Maddalena M G Rossi, Iris Walraven, et al.The Lancet. Oncology|November 27, 2025
Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 studyLi-Anne H Douma, Vincent van der Noort, Ferry Lalezari, et al.The Lancet. Oncology|October 16, 2023
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 studyLi-Anne H Douma, Ferry Lalezari, Vincent van der Noort, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 22, 2022
Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest GroupSharyn I Katz, Christopher M Straus, Leonid Roshkovan, et al.Pageof 3